Role of Gut-Derived Protein-Bound Uremic Toxins in Cardiorenal Syndrome and Potential Treatment Modalities

Circulation Journal : Official Journal of the Japanese Circulation Society
Suree Lekawanvijit

Abstract

Uremic toxins have been increasingly recognized as a crucial missing link in the cardiorenal syndrome. Advances in dialysis technologies have contributed to an enormous improvement in uremic toxin removal, but removal of protein-bound uremic toxins (PBUTs) by current conventional dialysis remains problematic because of their protein-binding capacity. Most PBUTs that have been implicated in cardiorenal toxicity have been demonstrated to be derived from a colonic microbiota metabolism pathway using dietary amino acids as a substrate. Currently, indoxyl sulfate and p-cresyl sulfate are the most extensively investigated gut-derived PBUTs. Strong evidence of adverse clinical outcomes, as well as biological toxicity on the kidney and cardiovascular system attributable to these toxins, has been increasingly reported. Regarding their site of origin, the colon has become a potential target for treatment of cardiorenal syndrome induced by gut-derived PBUTs.

References

Jan 1, 1972·Transactions - American Society for Artificial Internal Organs·A L BabbB H Scribner
Apr 1, 1984·Kidney International·S G RostandE A Rutsky
Apr 1, 1995·American Journal of Hypertension·K AmannG Mall
Feb 1, 1997·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B J BarrettR M Richardson
Oct 29, 1998·Biochemical and Biophysical Research Communications·J C BrownD T Monaghan
Nov 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R N FoleyM J Sarnak
Dec 23, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·G LesafferR Vanholder
Jul 20, 2000·European Heart Journal·J Thambyrajah, J N Townend
Nov 10, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·T MiyazakiT Niwa
Mar 20, 2001·The Journal of Clinical Investigation·M A HofmannA M Schmidt
Jul 31, 2001·JAMA : the Journal of the American Medical Association·H C GersteinUNKNOWN HOPE Study Investigators
Nov 13, 2002·Kidney International·Laetitia DouYvon Berland
Nov 26, 2002·BMJ : British Medical Journal·David S WaldJoan K Morris
Feb 26, 2003·Clinical Chemistry·Rita De SmetRaymond Vanholder
Mar 4, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Tsutomu SanakaShozo Koshikawa
Mar 4, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Yoshiharu TsubakiharaEnyu Imai
Mar 4, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Fumio TakayamaToshimitsu Niwa
Apr 5, 2003·Kidney International·Raymond VanholderUNKNOWN European Uremic Toxin Work Group (EUTox)
Oct 29, 2003·Circulation·Mark J SarnakUNKNOWN American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology,
Nov 8, 2003·Hypertension·Mark J SarnakUNKNOWN American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology,
Nov 25, 2003·Kidney International·Bert BammensPieter Evenepoel
Dec 4, 2003·Nephron. Experimental Nephrology·Masami SatohMasaru Motojima
Jan 21, 2004·Blood Purification·James F WinchesterNathan W Levin
May 25, 2004·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Tsutomu SanakaShozo Koshikawa
Jul 21, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ming-Ju WuMing-Jer Tang
Sep 24, 2004·The New England Journal of Medicine·Nagesh S AnavekarMarc A Pfeffer
Apr 9, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·R VanholderUNKNOWN European Uremic Toxin Work Group
Jan 26, 2006·American Journal of Physiology. Renal Physiology·Andrew K Gelasco, John R Raymond
Apr 14, 2006·Kidney International·H YamamotoE Kusano
Oct 17, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Eva SchepersRaymond Vanholder
Oct 24, 2006·American Journal of Nephrology·Naoki NakagawaKenjiro Kikuchi
Jan 12, 2007·American Journal of Nephrology·Kentaro TakiToshimitsu Niwa
Apr 4, 2007·Journal of Thrombosis and Haemostasis : JTH·L DouP Brunet

❮ Previous
Next ❯

Citations

Feb 5, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Sophie LiabeufGabriel Choukroun
Nov 22, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lenka TomasovaMarcin Ufnal
Sep 29, 2017·Korean Circulation Journal·Takehiro KamoIssei Komuro
May 31, 2018·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Tomasz HucMarcin Ufnal
Dec 7, 2018·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Emine M OnalMehmet Kanbay
Sep 13, 2019·Circulation. Genomic and Precision Medicine·Sharon CresciMatthew J Wolf
Feb 11, 2016·Journal of Atherosclerosis and Thrombosis·Shunsuke ItoMasayuki Yoshida
Apr 20, 2018·Physiological Reports·Adrian PostStephan J L Bakker
May 6, 2016·American Journal of Physiology. Renal Physiology·Suree LekawanvijitHenry Krum
Jun 13, 2018·Cardiac Failure Review·Conor P Kerley
Dec 12, 2020·Journal of Molecular and Cellular Cardiology·Petra MamicW H Wilson Tang
Nov 5, 2019·Diabetes & Metabolism·M Bastin, F Andreelli
Jun 8, 2021·Clinical Kidney Journal·Lynda CheddaniUNKNOWN NephroTest Study Group
Nov 11, 2021·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Piotr KonopelskiMarcin Ufnal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.